Summary
The FDAs decision to limit the regulation of certain general wellness wearables could leave clinicians to manage low-quality data risks, including patient anxiety and inaccurate readings.
Source: Techtarget.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
